INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Institute
![Foto de INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA](/img/noimage.png)
![Foto de Sociedad Española de Reumatología](/img/noimage_org.png)
Sociedad Española de Reumatología
Madrid, EspañaPublications in collaboration with researchers from Sociedad Española de Reumatología (32)
2024
2023
-
Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis
Clinical and experimental rheumatology, Vol. 41, Núm. 1, pp. 137-144
-
Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis—Multivariable Prediction Model Based on Machine Learning
Journal of Clinical Medicine, Vol. 12, Núm. 3
2022
-
Characteristics associated with the perception of high-impact disease (PsAID ≥4) in patients with recent-onset psoriatic arthritis. Machine learning-based model
Seminars in Arthritis and Rheumatism, Vol. 57
-
Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning
Arthritis research & therapy, Vol. 24, Núm. 1, pp. 153
-
Severe Disease in Patients With Recent-Onset Psoriatic Arthritis. Prediction Model Based on Machine Learning
Frontiers in Medicine, Vol. 9
2021
-
Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry
Clinical Rheumatology, Vol. 40, Núm. 10, pp. 3979-3988
2020
-
Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)
Lupus, Vol. 29, Núm. 1, pp. 27-36
-
Hormonal Dependence and Cancer in Systemic Lupus Erythematosus
Arthritis Care and Research, Vol. 72, Núm. 2, pp. 216-224
2019
-
Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry
Rheumatology International, Vol. 39, Núm. 3, pp. 509-515
-
Objectives and methodology of BIOBADASER phase III
Reumatologia Clinica, Vol. 15, Núm. 4, pp. 229-236
-
SER recommendations on the use of biological drugs in primary Sjögren's syndrome
Reumatologia Clinica, Vol. 15, Núm. 6, pp. 315-326
-
Spanish Registry of Recent-onset Psoriatic Arthritis (REAPSER study): Aims and methodology
Reumatologia Clinica, Vol. 15, Núm. 5, pp. 252-257
2018
-
Primary respiratory disease in patients with systemic lupus erythematosus: Data from the Spanish rheumatology society lupus registry (RELESSER) cohort
Arthritis Research and Therapy, Vol. 20, Núm. 1
-
Recommendations of the Spanish Society of Rheumatology on treatment and use of systemic biological and non-biological therapies in psoriatic arthritis
Reumatologia Clinica, Vol. 14, Núm. 5, pp. 254-268
-
Variability in the prescription of biological drugs in rheumatoid arthritis in Spain: a multilevel analysis
Rheumatology International, Vol. 38, Núm. 4, pp. 589-598
2017
-
Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort
Arthritis Care and Research, Vol. 69, Núm. 6, pp. 938-942
-
Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus
Seminars in Arthritis and Rheumatism, Vol. 47, Núm. 1, pp. 38-45
-
Juvenile- and adult-onset systemic lupus erythematosus: A comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)
Clinical and Experimental Rheumatology, Vol. 35, Núm. 6, pp. 1047-1055
-
Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project
Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3